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Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81 A63inducible molecule in T-lymphocytes, is a critical is a transcriptional
regulator that down-regulates MMPs in response to moderate loading
in chondrocytes. In this study, we tested the hypothesis that CITED2
mediates cross-talk between IL-4 and mechanical loading resulting in
synergistic chondroprotection by, at least in part, downregulating
MMPs such as MMP-13.
Methods: C28/I2 chondrocytic cells were treated with IL-4 (R&D) at
various concentrations, uniaxial tensile strain (5%, 1Hz, 1hr), or inter-
mittent hydrostatic pressure (5MPa, 1Hz, 1hr) in the presence of IL-1b,
and/or inhibitors of Jak3, or STAT6 (Santa Cruz). Cited2 and Mmp13
mRNA levels were analyzed by real-time PCRwith GAPDH as an internal
control. Phosphorylation of Jak3 and Stat6 was analyzed by Western
blot. IL-4 knockout mice or wild-type littermates (5- to 6-months-old,
male, n¼6/group) were treated with intra-articular injection of CITED2
siRNA, 24 hours before they were subjected to moderate treadmill
running at 10 m/min for 45 min. Mice with post-traumatic OA due to
destabilization of the medial meniscus (DMM) were subject to daily
intra-injections of PBS (control), or mouse recombinant IL-4 and either
hind limb immobilization or cage activity for 4 weeks (5- to 6-months-
old, male, n¼3/group). Cartilage integrity was evaluated by histological
scoring after Safranin O staining of ﬁxed sections. Signiﬁcant differences
were determined using one-way ANOVA with Tukey post-hoc test.
Results: IL-4 induces CITED2 in C28/I2 chondrocytic cells through the
Jak/Stat pathway: CITED2 gene expression was inducible by IL-4 in a
dose-dependent manner (Fig. 1A), with a time course of peak induction
at 8 hrs, declining thereafter (Fig 1B, and associated with down-
regulated MMP-13 gene expression. Targeted screening of signaling
pathways revealed that the induction of CITED2 by IL-4 was abolished
by JAK3- or STAT6-speciﬁc inhibitors (Fig 1C). Western blotting further
demonstrated that upregulation of CITED2 was mediated by phos-
phorylation of Jak3 and STAT6 (Fig 1D).
Combination of mechanical loading and a low dose of IL-4 ampliﬁes the
downregulation of MMP-13: Moderate mechanical loading (uniaxial
strain and IHP), when combined with IL-4 (1ng/ml), elevated CITED2
mRNA to a level signiﬁcantly higher than that induced by strain or IL-4
alone (Fig 2A, 2B), to a level similar to that achieved with a high dose of
IL-4 (10ng/ml, Fig 2A). Expression of MMP-13 was inversely correlated
inversely with CITED2 expression, and most signiﬁcantly down-
regulated in response to IL-4 and loading combined (Fig 2A, 2B). The
synergistic effects of loading and IL-4 were abolished in chondrocytes
when CITED2 was knocked down by siRNA prior to the relevant treat-
ment (Fig 2C).
IL-4 and mechanical loading exert synergistic chondroprotection in
vivo: Moderate treadmill running (10 m/min, 45 min) reduced Mmp13
mRNA levels in the knee articular cartilage of wild type mice. This
reductionwas partially abolished in IL-4 knockout mice and completely
abolished in the chondrocytes when CITED2 expression was knocked
down by intra-articular injection of Cited2 siRNA in knee joints (Fig 3A).
Furthermore, while intra-articular injections of mouse recombinant IL-
4 in DMM mice without mechanical loading (i.e. with their hind limb
immobilized) resulted in better preservation of the articular cartilage
compared to mice treated with PBS, IL-4, and loading (i.e., cage activity)
exerted the highest efﬁcacy in chondroprotection (Fig 3B).
Conclusions: We demonstrated: 1) IL-4 induces CITED2 expression in
chondrocytes, which ismediated by Jak/Stat signaling; 2) IL-4 combined
with mechanical loading exerts a synergistic chondroprotection in vitro
and in vivo. This study demonstrated a proof-of-concept for a potential
OA intervention with moderate loading, through exploiting the ability
of CITED2 to amplify the anti-catabolic effect of IL-4 and prevent side
effects of high doses of this cytokine.Figure 1. IL-4 includes CITED2 mRNA expression in a (A) dose and (B)
time-dependent manner in human C28/I2 chondrocytic cells. (C) IL-4-
induced is suppressed by Jak3 and STAT6 inhibitors and (D) CITED2
upregulation is associated with phosphorylation of Jak3 and STAT6, as
revealed by real-time PCR and Western blot, respectively.Figure 2. A low dose of IL-4 combined with either (A) uniaxial tensile
strain or (B) IHP synergistically induces CITED2 mRNA and suppresses
MMP-13 mRNA. (C) These effects are abolished by CITED2 knocked down
in C28/I2 chondrocytes transfected with CITED2 siRNA in the presence of
IL-1b.
Figure 3. (A) Moderate treadmill running-suppressed Mmp-13 expression
in the articular cartilage is diminished in IL4KO mice and completely
abolished in IL4KO mice with Cited2 knocked down. (B) DMM mice
subjected to IL-4 and cage activity (cage) exhibited efﬁcacy in chon-
droprotection The chondroprotective effect was diminished in DMM þ IL-
4 mice when the hind limb was immobilized (Imm, deloading). White
arrows indicate regions cartilage erosion or loss of proteoglycans.
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Purpose: The pathogenesis of osteoarthritis (OA) is poorly understood.
The earliest event is loss of the proteoglycan aggrecan from the car-
tilage matrix. Recently, we identiﬁed a signiﬁcant role for the JNK
pathway particularly JNK2 in regulation of aggrecan degradation by
human articular chondrocytes in vitro. To understand whether JNK2
plays a role maintaining cartilage integrity in vivo, we investigated the
development of osteoarthritis in JNK2 knockout mice using destabi-
lizing the medial meniscus OA surgical model (DMM). The role of JNK2
in inﬂammatory gene expression induced by DMM was also
investigated.
Methods: We ﬁrst compared the IL-1 responses of hip cartilage from
JNK2 knockout and wild-type C57BL6 mice. Proximal femoral epiphyses
were cultured in the presence or absence of IL-1. Aggrecan fragments
were analysed in the conditioned media by western blotting. OA was
induced by surgically destabilising the medial meniscus (DMM). Ani-
mals were sacriﬁced after 4, 8 and 12 weeks and sections taken through
the knees were stained with Safranin O. The medial compartments of
the knees were scored by a validated histological grading system for
aggrecan loss and cartilage damage. To test the effect of JNK2 deﬁciency
on inﬂammatory gene regulation, RNA was extracted from JNK2
knockout and wildtype knees 6hrs following DMM. Gene expression
proﬁles of 48 DMM-regulated genes (previously reported by our group)
were analysed by q-PCR using customized Taqman Low Density Array
(TLDA) cards.
Results: IL-1 failed to generate aggrecanase-mediated aggrecan frag-
ments in the JNK2 knockout cartilage compared with wild type con-
trols. The JNK2 knockout animals showed signiﬁcant reduction of
cartilage damage at all time points compared with wild-type operated
animals, indicating that activity in the JNK pathway contributes to
aggrecan loss and cartilage damage in vivo. Of the 48 genes inves-
tigated, 12 genes were signiﬁcantly down-regulated in JNK2 knockout
mice following DMM compared with wildtype controls. This panel of
Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81A64deregulated genes included Has1, ADAMTS4, Tnf, IL6, IL18, Inhba, Cd68,
Ngf, Ccr2, Wnt 16, Tnfaip6 and Il1r.
Conclusions: Deletion of JNK2 retarded the development of exper-
imental murine OA, showing the importance of the kinase for cartilage
homeostasis in vivo and implicating an intracellular signalling pathway
in OA for the ﬁrst time.
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Purpose: We aimed to understand the mechanism by which mem-
brane-type 1 matrix metalloproteinase (MT1-MMP, MMP-14) controls
bone and cartilage homeostasis. MT1-MMP, a cell-membrane-bound
proteinase with an extracellular catalytic site and a 20-amino acid
cytoplasmic tail, degrades the extracellular matrix and plays a key role
in postnatal bone formation. MT1-MMP is overexpressed in osteo-
arthritis, and mutation of MT1-MMP in humans causes the multicentric
osteolysis and arthritis disease, Winchester syndrome. The genetic
deﬁciency of MT1-MMP (MT1-MMP-/-) in the mouse causes dwarﬁsm,
osteopenia and severe arthritis. Conditional deletion of MT1-MMP in
bone marrow-derived mesenchymal progenitor cells (BM-MSC) fully
recapitulates this phenotype, showing that MT1-MMP controls osteo-
genic differentiation inMSC. It has been proposed that the phenotype of
MT1-MMP-/- mice results from the lack of MT1-MMP proteolytic
activity. However, mounting evidence shows a variety of proteolysis-
independent functions of MT1-MMP. The unique tyrosine (Y573) in the
MT1-MMP cytoplasmic tail is fundamental for the control of intra-
cellular signaling. We have shown that Y573 mediates Ras-ERK1/2
signaling, and that Y573 mutation (Y573D) blocks this functionwithout
affecting MT1-MMP proteolytic activity.
Methods: We generated a mouse with the Y573D mutation in MT1-
MMP (MT1-MMP Y573D) and characterized its skeletal phenotype by
histological and microCT analyses. We isolated BM-MSC and induced
them to differentiate into osteoblasts, chondrocytes and adipocytes,
using qRT-PCR to analyze gene expression. Mouse C3H10T1/2MSCwere
transfected with MT1-MMP cDNA and analyzed for Wnt signaling and
Runx2 activation by luciferase reporter assays.
Results: Analysis of the long bones of both homozygote and heterozygote
MT1-MMP Y573D mice showed increased trabecular bone relative to wt
littermates (BV/TV %; - wt: 10 4±8; homo: 23.2±2.0; Tb.Th (mm) - wt:
20.5±3.8; homo: 40.1±7.0; Tb.N./mm - wt: 10.5±4.2; homo: 19.5 4.2;
Tb.Sp (mm): 325.2±52.1; 190.6 49.1; p0.01), a phenotypeopposite to that
of MT1-MMP-/- mice. MT1-MMP Y573D mice also showed marked thin-
ning of articular cartilage, with disorganized tissue architecture, cluster-
ing and cloning of chondrocytes, as well as pronounced decrease in bone
marrow-associated and total body fat (fat weight/body weight - wt:
0.270±0.0105; homo: 0.0135±0.006; p¼0.0029). These ﬁndings indicated
a defect in MSC differentiation. Therefore, we isolated BM-MSC from wt
and homozygous mutant littermates, and induced them to differentiate
into osteoblast and chondrocytes, and myeloid precursors were induced
to differentiate into osteoclasts. The Y573D mutation dramatically
increased MSC expression of osteoblast markers (ALP, COL1, BSP, OCN,
RUNX2) and strongly downregulated chondrocyte (ADA4, ADA5, SOX9,
MMP13) and osteoclast markers (TRACP, CALCR, CTSK, DC-STAMP, MMP9,
iNOS). These ﬁndings indicated thatWnt signaling is upregulated inMT1-
MMP Y573D-expressing MSC. The canonical Wnt pathway is indeed
unique, as it exerts opposite effects on osteoblast and chondrocyte dif-
ferentiation fromMSC. Therefore, we analyzedWnt signaling and Runx2
activation. We transiently transfected C3H10T1/2 MSC cells in osteoblast
medium with the cDNAs for wt MT1-MMP and MT1-MMP Y573D. As
controls the cellswere transfectedwith the empty vector (pcDNA) orwith
MT1-MMP E240A, a mutant devoid of proteolytic activity. MT1-MMPY573D dramatically upregulated both Wnt signaling (2.8-4.6-fold;
p¼0.007) and Runx2 activity (8.7-46.5-fold; ¼0.009) relative to wt MT1-
MMP and MT1-MMP E240A.
Conclusions: MT1-MMP controls Wnt signaling by a mechanism
independent of extracellular proteolysis and mediated by its cytoplas-
mic tail. MT1-MMP is a bifunctional protein, with an extracellular
proteolytic activity that promotes bone formation through ECM
remodeling and a cytoplasmic tail that controls osteogenesis by inter-
acting with a key pro-osteogenic signaling pathway.
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Purpose: The role of the NOTCH signaling pathway in articular cartilage
maintenance and osteoarthritis (OA) is controversial. Using conditional
NOTCH loss-of-function murine genetic models, we recently identiﬁed
the NOTCH signaling pathway as a critical regulator of joint cartilage
maintenance, while others have identiﬁed an increase in the expression
and activation of NOTCH signaling components in post-traumatic
murine and human OA. Therefore, we set out to determine whether
NOTCH signaling promotes joint cartilage maintenance, contributes to
the pathogenesis of OA, or potentially both depending on the strength
and/or duration of the signal.
Methods: To solve this questionwe developed two novel genetic mouse
models that allowed for either sustained NOTCH activation that likely
resembles pathological NOTCH signaling or transient NOTCH activation
that may more closely reﬂect physiological NOTCH signaling in joint
tissues. In vivo changes to joint and cartilage structure and gene
expression was monitored using histology, histomorphometry, real-
time qPCR, and immunohistochemistry (IHC). Furthermore, we devel-
oped an in vitro NOTCH gain-of-function primary chondrocyte culture
model, which mimicked our in vivo sustained NOTCH activation mouse
model, and performed large scale RNA-sequencing (RNAseq) to identify
direct and indirect targets of NOTCH signaling in cartilage. Numerous
targets were subsequently validated via in vitro models (primary
chondrocytes and ATDC5 cells), as well as, NOTCH-induced and post-
traumatic murine OA models using real-time qPCR, Western analysis,
and IHC.
Results: Our data demonstrate for the ﬁrst time that sustained versus
transient NOTCH activation in postnatal murine joint cartilages leads to
opposing effects on articular cartilage and joint maintenance. This study
establishes that sustained NOTCH activation in adult joint cartilage
results in a severe, early, and progressive OA-like pathology, while
transient NOTCH activation results in increased cartilage extracellular
matrix synthesis and joint maintenance under physiological conditions.
In vitro and in vivo studies demonstrate the capability of NOTCH sig-
naling to regulate both anabolic (Sox9, Col2a1, Acan, etc/) and catab-
olic gene expression (Mmp13, Adamts4, Adamts5, etc/), and RNAseq
experiments determined that sustained NOTCH activation suppresses
chondrogenic genes but promotes the expression of cartilage-related
proteases, ﬁbrotic collagens, and inﬂammatory factors including Il6.
Utilizing both in vivo and in vitro sustained NOTCH activation models
we demonstrate that the NOTCH-mediated suppression of chondro-
genic regulators, as well as, the activation of ﬁbrotic and catabolic fac-
tors may at least be partially mediated via NOTCH/IL6/ERK and NOTCH/
IL6/STAT3 signaling mechanisms, respectively. Furthermore, we show
that many of the NOTCH-induced signals leading to joint degeneration
are similarly affected in a post-traumatic OA mouse model.
Conclusions: Collectively, our data indicate that NOTCH signaling is a
critical pathway that regulates joint cartilage homeostasis and in
pathological situations of sustained signaling is involved in joint carti-
lage degradation, ﬁbrosis, and chondrogenic gene suppression. There-
fore, an appropriate balance of NOTCH signaling must be achieved
throughout life and following joint injury in order to maintain articular
cartilage homeostasis and joint integrity.
